Skip to main content

Table 2 Outcome scores and estimates of effects of all outcome measures for the control group and experimental group.

From: Feasibility and results of a randomised pilot-study of pre-discharge occupational therapy home visits

   OUTCOME SCORE ANCOVA-ADJUSTED ESTIMATES OF EFFECTS* p-value
Outcome Measure   Control Experimental   
Functional Independence Measure: total score (sd), 0–126 2 weeks 115.2 (± 6.3) 117.7 (± 3.3) 2.5 (-6.7 to 11.9) .525
  1 month 116.5 (± 7.4) 117.7 (± 3.9) 1.3 (-10.6 to 13.27) .788
  2 months 112.2 (± 10.0) 120.0 (± 2.1) 8.72 (-3.4 to 20.9) .125
  3 months 118.0 (± 4.0) 115.7 (± 6.8) -0.1 (-13.9 to 13.8) .982
Reintegration to Normal Living Index: total score (sd), 0–100 2 weeks 59.2 (± 20.3) 63.0 (± 9.6) 4.1 (-27.5 to 35.6) .754
  1 month 56.7 (± 23.7) 56.2 (± 15.8) 0.8 (-34.8 to 36.5) .953
  2 months 53.2 (± 38.6) 83.0 (± 9.5) 30.5 (-39.7 to 100.8) .294
  3 months 83.6 (± 9.8) 82.0 (± 8.2) -1.7 (-22.8 to 19.4) .835
Nottingham Extended Activities of Daily Living scale: total score (sd), 0–66 2 weeks 37.2 (± 10.9) 45.7 (± 5.9) 16.1 (4.9 to 27.1) .012
  1 month 33.7 (± 20.1) 46.7 (± 3.4) 17.0 (-12.88 to 46.95) .203
  2 months 36.0 (± 13.9) 51.7 (± 3.1) 23.0 (12.2 to 33.8) .003
  3 months 43.3 (± 7.1) 56.7 (± 2.2) 17.6 (-3.2 to 38.5) .079
Tinnetti Performance Oriented Mobility Scale: total score (sd) 0–28 2 weeks 20.3 (± 2.9) 20.0 (± 1.4) 0.5 (-3.0 to 4.2) .639
  1 month 22.0 (± 1.4) 24.0 (± 6.9) 2.2 (-8.9 to 13.2) .639
  2 months 17.0 (± 11.5) 22.7 (± 2.7) 2.7 (-13.9 to 19.3) .694
  3 months 23.0 (± 1.7) 23.5 (± 1.7) 0.5 (-3.8 to 4.8) .779
Falls Efficacy Scale- International: total score (sd), 0–64 2 weeks 33.6 (± 7.1) 30.2 (± 8.9) -2.3 (-18.1 to 13.5) .735
  1 month 31.5 (± 8.0) 28.5 (± 7.3) -2.5 (-19.8 to 14.7) .722
  2 months 36.2 (± 9.5) 23.2 (± 4.2) -14.8 (-30.7 to 1.17) .063
  3 months 30.0 (± 3.0) 22.2 (± 4.5) -3.2 (-10.5 to 4.1) .287
EQ-5D VAS: total score (sd), 0–100 2 weeks 35.2 (± 30.8) 69.2 (± 11.3) 21.4 (-21.1 to 64.0) .252
  1 month 62.25 (± 18.0) 79.3 (± 10.1) 8.6 (-21.4 to 38.8) .470
  2 months 48.3(± 32.4) 87.0 (± 9.2) 31.7 (-23.4 to 86.9) .185
  3 months 54.0 (± 25.0) 85.0 (± 8.5) 23.3 (-17.4 to 64.1) .187
  1. * Between-group differences adjusted for the baseline value of the outcome Larger scores reflect decreased risk except for the FES-I